Industrial

Anyone tracking Biologics Manufacturing News this year has noticed the same pattern repeating across press releases, investor calls, and trade publications: artificial intelligence and automation are no longer experimental add-ons in drug production — they are becoming the backbone of how biologics get made. From continuous bioprocessing lines that self-adjust in real time to machine-learning … Read more